Cleared Traditional

K133355 - CADWELL FLEX EEG/PSG

K133355 is an FDA 510(k) clearance for CADWELL FLEX EEG/PSG, manufactured by Cadwell Industries, Inc.. The device is a Class 2 Neurology device with product code GWQ cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K133355 · Cadwell Industries, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2014
Decision
90d
Days
Class 2
Risk

K133355 is an FDA 510(k) clearance for the CADWELL FLEX EEG/PSG. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Cadwell Industries, Inc. (Kennewick, US). The FDA issued a Cleared decision on January 29, 2014 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cadwell Industries, Inc. devices

FDA 510(k) Submission Details - K133355

510(k) Number K133355 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2013
Decision Date January 29, 2014
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 149d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWQ Device Classification - Class 2, Special Controls

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 153
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K133355.
Natus Quantum
K143440 · Natus Medical Incorporated · Apr 2015
BWMINI EEG, BWMINIHST, BWMINI PSG
K131335 · Neurovirtual USA, Inc. · Feb 2015
TREZ_HD
K131266 · Excel-Tech Ltd. (Xltek) · Feb 2014
X10 HEADSET WITH X-SERIES BASIC SOFTWARE, X24 HEADSET WITH X-SERIES BASIC SOFTWARE
K131383 · Advanced Brain Monitoring, Inc. · Nov 2013
CERVELLO BIO-POTENTIAL SIGNAL ACQUISTION SYSTEM PRODUCT FAMILY
K122196 · Blackrock Neuromed, LLC · May 2013
PSG-1100 SLEEP DIAGNOSTIC SYSTEM
K120888 · Nihon Kohden Corp. · Nov 2012